Cancer stem cells: current status and evolving complexities.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cell Stem Cell

• Publication date

  2012-06-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.stem.2012.05.007PMID 22704512
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hedgehog and Notch signaling regulate self-renewal of undifferentiated pleomorphic sarcomas.

  2012cited by this paper
• Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis.

  2012cited by this paper
• Decoupling of tumor-initiating activity from stable immunophenotype in HoxA9-Meis1-driven AML.

  2012cited by this paper
• TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells

  2012cited by this paper
• A small molecule screening strategy with validation on human leukemia stem cells uncovers the therapeutic efficacy of kinetin riboside.

  2012cited by this paper
• Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells

  2011cited by this paper
• Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions

  2011cited by this paper
• Evolution of human BCR–ABL1 lymphoblastic leukaemia-initiating cells

  2011cited by this paper
• A vascular niche and a VEGF–Nrp1 loop regulate the initiation and stemness of skin tumours

  2011cited by this paper
• Interactions between cancer stem cells and their niche govern metastatic colonization

  2011cited by this paper
• The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse.

  2011cited by this paper
• Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271

  2011influential reference
• Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state

  2011cited by this paper
• Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia.

  2011cited by this paper
• Direct In Vivo Evidence for Tumor Propagation by Glioblastoma Cancer Stem Cells

  2011cited by this paper
• Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.

  2011cited by this paper
• L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1

  2011cited by this paper
• Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy.

  2011cited by this paper
• Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth.

  2011cited by this paper
• Genetic variegation of clonal architecture and propagating cells in leukaemia

  2011cited by this paper
• Distinct types of tumor-initiating cells form human colon cancer tumors and metastases.

  2011influential reference
• Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells

  2011influential reference
• Stem cell gene expression programs influence clinical outcome in human leukemia

  2011influential reference
• Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia.

  2011cited by this paper
• The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells.

  2011cited by this paper
• c-Met is a marker of pancreatic cancer stem cells and therapeutic target.

  2011cited by this paper
• Complete kinetochore tracking reveals error-prone homologous chromosome biorientation in mammalian oocytes.

  2011cited by this paper
• Evolution of human BCR–ABL1 lymphoblastic leukaemia-initiating cells

  2011cited by this paper
• Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells.

  2011cited by this paper
• Acidic stress promotes a glioma stem cell phenotype

  2011cited by this paper
• Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells

  2011cited by this paper
• Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF-β and integrin/focal adhesion kinase (FAK) signaling

  2011cited by this paper
• Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3.

  2011cited by this paper
• Using a stem cell-based signature to guide therapeutic selection in cancer.

  2011cited by this paper
• Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2.

  2011cited by this paper
• Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice.

  2011cited by this paper
• Primary tumor genotype is an important determinant in identification of lung cancer propagating cells.

  2010cited by this paper
• Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia.

  2010cited by this paper
• Identification of miR-34a as a potent inhibitor of prostate cancer progenitor cells and metastasis by directly repressing CD44

  2010cited by this paper
• Human Melanoma Initiating Cells Express Neural Crest Nerve Growth Factor Receptor CD271

  2010cited by this paper
• TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells.

  2010cited by this paper
• Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized.

  2010cited by this paper
• Persistent malignant stem cells in del(5q) myelodysplasia in remission.

  2010cited by this paper
• A hierarchy of self-renewing tumor-initiating cell types in glioblastoma.

  2010cited by this paper
• Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content.

  2010cited by this paper
• The microRNA miR-34 a inhibits prostate cancer stem cells and metastasis by directly repressing CD 44

  2010cited by this paper
• Glioblastoma stem-like cells give rise to tumour endothelium

  2010influential reference
• CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts.

  2010cited by this paper
• Bone progenitor dysfunction induces myelodysplasia and secondary leukemia

  2010cited by this paper
• The Wnt/β-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML

  2010cited by this paper
• A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer.

  2010cited by this paper
• CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer.

  2010cited by this paper
• Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models

  2010cited by this paper
• A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.

  2010cited by this paper
• Integrin alpha 6 regulates glioblastoma stem cells.

  2010cited by this paper
• Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells.

  2010cited by this paper
• Wnt activity defines colon cancer stem cells and is regulated by the microenvironment

  2010cited by this paper
• A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations.

  2010cited by this paper
• Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML

  2010cited by this paper
• Targeting Hedgehog — a Cancer Stem Cell Pathway

  2010cited by this paper
• Selective targeting of radiation-resistant tumor-initiating cells

  2010cited by this paper
• Tumor-initiating cells are rare in many human tumors.

  2010cited by this paper
• Association of reactive oxygen species levels and radioresistance in cancer stem cells

  2009cited by this paper
• The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells.

  2009cited by this paper
• Identification of selective inhibitors of cancer stem cells by high-throughput screening.

  2009cited by this paper
• Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.

  2009cited by this paper
• CD133 Expression Defines a Tumor Initiating Cell Population in Primary Human Ovarian Cancer

  2009cited by this paper
• Notch Promotes Radioresistance of Glioma Stem Cells

  2009cited by this paper
• Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells.

  2009influential reference
• Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells

  2009cited by this paper
• Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

  2009cited by this paper
• Mouse differentiating spermatogonia can generate germinal stem cells in vivo

  2009cited by this paper
• Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewal.

  2009influential reference
• Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia

  2009cited by this paper
• SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma.

  2009cited by this paper
• Multipotent CD15+ cancer stem cells in patched-1-deficient mouse medulloblastoma.

  2009cited by this paper
• Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells.

  2009influential reference
• DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency.

  2009influential reference
• Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma.

  2009cited by this paper
• The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype

  2009cited by this paper
• Faculty Opinions recommendation of Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling.

  2008cited by this paper
• Efficient tumor formation by single human melanoma cells

  2008cited by this paper
• Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling

  2008cited by this paper
• Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells.

  2008cited by this paper
• Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia.

  2008cited by this paper
• Module map of stem cell genes guides creation of epithelial cancer stem cells.

  2008cited by this paper
• The epithelial-mesenchymal transition generates cells with properties of stem cells.

  2008cited by this paper
• Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation.

  2008cited by this paper
• Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

  2008cited by this paper
• Efficient tumour formation by single human melanoma cells

  2008cited by this paper
• Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.

  2008cited by this paper
• PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo.

  2008cited by this paper
• Making a tumour's bed: glioblastoma stem cells and the vascular niche

  2007influential reference
• The Genomic Landscapes of Human Breast and Colorectal Cancers

  2007cited by this paper
• ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

  2007cited by this paper
• Phenotypic characterization of human colorectal cancer stem cells

  2007cited by this paper
• let-7 regulates self renewal and tumorigenicity of breast cancer cells.

  2007cited by this paper
• Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer.

  2007cited by this paper
• Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia.

  2006cited by this paper
• Targeting of CD44 eradicates human acute myeloid leukemic stem cells

  2006influential reference

• ENOX2 (tNOX)–Associated Stemness in Oral Cancer Cells and Its Clinical Correlation in Head and Neck Tumors

  2026cites this paper
• Prophylactic and therapeutic CSC-based vaccination reduced tumor growth, metastasis and enhanced survival in mouse model of breast cancer.

  2026cites this paper
• Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance

  2025cites this paper
• Shifting the Spotlight to Low-Dose Rate Radiobiology in Radiopharmaceutical Therapies: Mathematical Modeling, Challenges, and Future Directions

  2025cites this paper
• Recent Advances in Theranostic-based Extracellular Vesicles in Cancer Stem Cell Diagnosis and Therapy.

  2025cites this paper
• Molecular Mechanisms of Dietary Compounds in Cancer Stem Cells from Solid Tumors: Insights into Colorectal, Breast, and Prostate Cancer

  2025cites this paper
• Emerging mechanisms of therapy resistance in metastatic ER+ breast cancer.

  2025cites this paper
• Investigation of anti-cancer efficiency of DZNep and Stauprimide combination in breast cancer

  2025cites this paper
• Recent advances in targeting COX-2 for cancer therapy: a review.

  2025cites this paper
• Targeting epithelial-mesenchymal transition signaling pathways with Dietary Phytocompounds and repurposed drug combinations for overcoming drug resistance in various cancers

  2025cites this paper
• Biology of stem cell paradox: a double-edged sword-implications for cancer therapy

  2025cites this paper
• Oxidative Stress and Redox Imbalance: Common Mechanisms in Cancer Stem Cells and Neurodegenerative Diseases

  2025cites this paper
• Differentiation hierarchy in adult B cell acute lymphoblastic leukemia at clonal resolution

  2025cites this paper
• Glioblastoma Stem Cells at the Nexus of Tumor Heterogeneity, Immune Evasion, and Therapeutic Resistance

  2025cites this paper
• The dual role of autophagy in cancer stem cells: implications for tumor progression and therapy resistance

  2025cites this paper
• LncRNA TSPEAR-AS2 Maintains the Stemness of Gastric Cancer Stem Cells by Regulating the miR-15a-5p/CCND1 Axis

  2025cites this paper
• The synergistic effect of 2-deoxy-D-glucose and cytarabine on mitochondria of stem-like cells derived from KG1-a

  2025cites this paper
• The immunomodulatory role of tumor-initiating cells in digestive system tumors: from mechanisms to therapy

  2025cites this paper
• High Expression of PKCζ And CTNNBIP1 Is Associated With Poor Prognosis in Luminal B Breast Cancer

  2025cites this paper
• Raman Spectroscopies for Cancer Research and Clinical Applications: a Focus on Cancer Stem Cells.

  2025cites this paper
• GPLD1+ cancer stem cells contribute to chemotherapy resistance and tumor relapse in intestinal cancer.

  2025cites this paper
• PKCζ, CTNNBIP1 and ALDH1A3 Expression in Luminal B Breast Cancer Indicates Decreased Hormone Therapy Effectiveness

  2025cites this paper
• Regnase-1 Promotes Tumor-Initiating Activity in Non-Small Cell Lung Cancer

  2025cites this paper
• Interferons as therapeutic orchestrators of cancer stem cell plasticity and therapy response.

  2025cites this paper
• Fine-Tuning Side Chain Substitutions: Impacts on the Lipophilicity–Solubility–Permeability Interplay in Macrocyclic Peptides

  2025cites this paper
• Super-Charged Natural Killer Cells: A Promising Immunotherapeutic Strategy for Oral Cancer

  2025cites this paper
• ECD co-operates with ERBB2 to promote tumorigenesis through upregulation of unfolded protein response and glycolysis.

  2025cites this paper
• High p62 and ALDH1A3 Reduce the Effectiveness of Endocrine Therapy in Luminal B Breast Cancer

  2025cites this paper
• A scaffold repositioning approach: dihydroBenzoImidazoTriazineDione (BITD) derivatives as selective ALDH1A1 inhibitors

  2025cites this paper
• Novel cancer stem cell-targeted retinoid ZSH-512 impedes colorectal cancer progress via KDM3A-mediated epigenetic reprogramming

  2025cites this paper
• Heterogeneous protein dynamics links to mitochondrial activity, glucose transporter, and ALDH cancer stem cell properties

  2025cites this paper
• The role of SOX transcription factors in prostate cancer: Focusing on SOX2

  2025cites this paper
• Regulatory Functions of microRNAs in Cancer Stem Cells: Mechanism, Facts, and Perspectives

  2025cites this paper
• Revolutionizing Breast Cancer Therapeutics: Intersecting Frontiers of Precision Medicine, Nanotechnology, and Drug Delivery Innovations

  2025cites this paper
• Long non-coding RNAs: Key regulators of stemness in breast cancer

  2025cites this paper
• High Expression of PKCζ and ALDH1A3 Is Associated With Poor Prognosis in Luminal B Breast Cancer

  2025cites this paper
• Cancer Stem Cells Decide the Fate of Cancer Immunotherapy by Remodeling Tumor Microenvironment

  2025cites this paper
• Stilbenes from Vine Extracts: Therapeutic Potential and Mechanisms

  2025cites this paper
• Redox–Amino Acid Metabolic Crosstalk in Ovarian Cancer Stem Cells: Integrating Metabolic Reprogramming, Signaling, and the Tumor Microenvironment

  2025cites this paper
• Asymmetric cell division of ALDH1-positive cancer stem cells generates glycolytic metabolically diverse cell populations

  2025cites this paper
• Advanced drug delivery platforms target cancer stem cells

  2025cites this paper
• Loss of LATS1 and LATS2 promotes ovarian tumor formation by enhancing AKT activity and PD-L1 expression

  2025cites this paper
• C-terminally phosphorylated p27 activates self-renewal driver genes to program cancer stem cell expansion, mammary hyperplasia and cancer

  2024cites this paper
• VDAC1-Based Peptides as Potential Modulators of VDAC1 Interactions with Its Partners and as a Therapeutic for Cancer, NASH, and Diabetes

  2024cites this paper
• Targeting signaling pathways in cancer stem cells: A potential approach for developing novel anti-cancer therapeutics.

  2024cites this paper
• Identification of Crucial Cancer Stem Cell Genes Linked to Immune Cell Infiltration and Survival in Hepatocellular Carcinoma

  2024cites this paper
• Self-assembled aldehyde dehydrogenase-activatable nano-prodrug for cancer stem cell-enriched tumor detection and treatment

  2024cites this paper
• Macrophage-Derived Exosomes Promoted the Development and Stemness of Inflammatory Bowel Disease-Related Colorectal Cancer via nuclear paraspeckle assembly transcript 1-Mediated miRNA-34a-5p/phosphoprotein enriched in astrocytes 15 Axis.

  2024cites this paper
• Expressions and Clinical Significance of Met and YAP in Gastric Cancer Tissue Microarray

  2024cites this paper
• ZSH‐2208: A novel retinoid with potent anti‐tumour effects on ESCC stem cells via RARγ–TNFAIP3 axis

  2024cites this paper
• DOT1L Mediates Stem Cell Maintenance and Represents a Therapeutic Vulnerability in Cancer

  2024cites this paper
• PAF1-mediated transcriptional reprogramming confers docetaxel resistance in advanced prostate cancer.

  2024cites this paper
• Mitochondria’s Role in the Maintenance of Cancer Stem Cells in Hepatocellular Carcinoma

  2024cites this paper
• The future of metronomic chemotherapy: experimental and computational approaches of drug repurposing

  2024cites this paper
• Analysis and experimental validation of disulfidptosis related genes solute carrier family 3 member 2 (SLC3A2) in endometrial cancer

  2024cites this paper
• Standard chemotherapy impacts on in vitro cellular heterogeneity in spheroids enriched with cancer stem cells (CSCs) derived from triple-negative breast cancer cell line.

  2024cites this paper
• JARID2 activation by NFYA promotes stemness of triple-negative breast cancer cells through the PI3K/AKT pathway

  2024cites this paper
• KLF15 suppresses stemness of pancreatic cancer by decreasing USP21-mediated Nanog stability

  2024cites this paper
• Co‑expression of SLC20A1 and ALDH1A3 is associated with poor prognosis, and SLC20A1 is required for the survival of ALDH1‑positive pancreatic cancer stem cells

  2024cites this paper
• Intricate relationship between cancer stemness, metastasis, and drug resistance

  2024cites this paper
• Enhancing Therapeutic Efficacy of FLT3 Inhibitors with Combination Therapy for Treatment of Acute Myeloid Leukemia

  2024cites this paper
• Surface Engineering of Magnetic Iron Oxide Nanoparticles for Breast Cancer Diagnostics and Drug Delivery

  2024cites this paper
• Silencing the Mitochondrial Gatekeeper VDAC1 as a Potential Treatment for Bladder Cancer

  2024cites this paper
• Targeting Pivotal Hallmarks of Cancer for Enhanced Therapeutic Strategies in Triple-Negative Breast Cancer Treatment—In Vitro, In Vivo and Clinical Trials Literature Review

  2024cites this paper
• Human esophageal cancer stem-like cells escape the cytotoxicity of natural killer cells via down-regulation of ULBP-1

  2024cites this paper
• Integrative multi‐omic and machine learning approach for prognostic stratification and therapeutic targeting in lung squamous cell carcinoma

  2024cites this paper
• Generation of 3D melanoma models using an assembloid-based approach.

  2024cites this paper
• SOX2 Expression Does Not Guarantee Cancer Stem Cell-like Characteristics in Lung Adenocarcinoma

  2024cites this paper
• Senescence Promotes the Recovery of Stemness among Cancer Cells via Reprograming

  2024cites this paper
• Identification of TNFRSF21 as an inhibitory factor of osteosarcoma based on a necroptosis-related prognostic gene signature and molecular experiments

  2024cites this paper
• Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies

  2024cites this paper
• Tumor-derived apoptotic extracellular vesicle-mediated intercellular communication promotes metastasis and stemness of lung adenocarcinoma

  2024cites this paper
• The Potential of Epigallocatechin Gallate in Targeting Cancer Stem Cells: A Comprehensive Review.

  2024cites this paper
• EXOSC5 maintains cancer stem cell activity in endometrial cancer by regulating the NTN4/integrin β1 signalling axis

  2024cites this paper
• EKSPRESI MnSOD PADA BREAST CANCER CELL LINE MENGGUNAKAN TEKNIK qRT-PCR (QUANTITATIVE REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION)

  2024cites this paper
• Aligning Cancer Research Priorities in Europe with Recommendations for Conquering Cancer: A Comprehensive Analysis

  2024cites this paper
• Boric Acid Affects the Expression of DNA Double-Strand Break Repair Factors in A549 Cells and A549 Cancer Stem Cells: An In Vitro Study

  2024cites this paper
• Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation

  2024cites this paper
• The Role of Hedgehog Signaling Pathway in Head and Neck Squamous Cell Carcinoma

  2023cites this paper
• Methionine orchestrates the metabolism vulnerability in cisplatin resistant bladder cancer microenvironment

  2023cites this paper
• The Mechanics of Tumor Cells Dictate Malignancy via Cytoskeleton-Mediated APC/Wnt/β-Catenin Signaling

  2023cites this paper
• Formulation and characterization of cisplatin-loaded hydroxyl functionalized single-walled carbon nanotubes for targeting gastric cancer stem cells

  2023cites this paper
• Single-cell trajectory analysis reveals a CD9 positive state to contribute to exit from stem cell-like and embryonic diapause states and transit to drug-resistant states

  2023cites this paper
• CDK7-YAP-LDHD axis promotes D-lactate elimination and ferroptosis defense to support cancer stem cell-like properties

  2023cites this paper
• WNT2–SOX4 positive feedback loop promotes chemoresistance and tumorigenesis by inducing stem-cell like properties in gastric cancer

  2023cites this paper
• The Yin and Yang of Breast Cancer: Ion Channels as Determinants of Left–Right Functional Differences

  2023cites this paper
• Bispecific antibodies targeting EGFR/Notch enhance the response to talazoparib by decreasing tumour-initiating cell frequency

  2023cites this paper
• The Glioblastoma Landscape: Hallmarks of Disease, Therapeutic Resistance, and Treatment Opportunities

  2023cites this paper
• A critical appraisal of the relative contribution of tissue architecture, genetics, epigenetics and cell metabolism to carcinogenesis.

  2023cites this paper
• Molecular Characterization and Landscape of Breast cancer Models from a multi-omics Perspective

  2023cites this paper
• A novel predictive model based on inflammatory response-related genes for predicting endometrial cancer prognosis and its experimental validation

  2023cites this paper
• Molecular Mechanisms of Tumor Cell Stemness Modulation during Formation of Spheroids

  2023cites this paper
• Regulation of iron metabolism and ferroptosis in cancer stem cells

  2023cites this paper
• An Isoxazoloquinone Derivative Inhibits Tumor Growth by Targeting STAT3 and Triggering Its Ubiquitin-Dependent Degradation

  2023cites this paper
• Estrogen Receptor β4 Regulates Chemotherapy Resistance and Induces Cancer Stem Cells in Triple Negative Breast Cancer

  2023cites this paper
• Knockdown of hnRNPAB reduces the stem cell properties and enhances the chemosensitivity of human colorectal cancer stem cells.

  2023cites this paper
• NAD(P)H Quinone Oxidoreductase-1 Expression Promotes Self-Renewal and Therapeutic Resistance in Non-Small Cell Lung Cancer

  2023cites this paper
• 1′-O-methyl-averantin isolated from the endolichenic fungus Jackrogersella sp. EL001672 suppresses colorectal cancer stemness via sonic Hedgehog and Notch signaling

  2023cites this paper
• Immunotargeting of Cancer Stem Cells

  2023cites this paper
• FOXD1 promotes chemotherapy resistance by enhancing cell stemness in colorectal cancer through β‑catenin nuclear localization

  2023cites this paper